Breast cancer claims younger black female lives. If so, when should the screening begin?

Published Date: 26 Apr 2023

Once a woman turns 40, experts advise that she at the very least think about starting a breast cancer screening program. According to a recent study, Black women need this advice above all others.

Read Full News

Latest News

Bannwarth Syndrome in a Woman With Early Breast Cancer

The case emphasizes Bannwarth syndrome as a rare but treatable cause of neurologic deterioration in an older woman receiving surgical cancer care.

Can Large Language Models Simplify Radiology Reports?

A meta-analysis suggests that large language model-simplified radiology reports improve patient understanding and readability while preserving high accuracy and completeness.

NPH: What You Learned in Med School Is Wrong

Neurologists Indu Subramanian and Alfonso Fasano discuss normal pressure hydrocephalus and why some of the classic dogma about this condition is wrong.

Promoting Whole-Body Imaging: Not There Yet

Ethicist Art Caplan discusses marketing promotions for expensive whole-body imaging.

Medicine Will Turn Cellular Age Backward by 2050: Barzilai

Aging may not be permanent. Nir Barzilai explains how human cells reset to zero and why partial rejuvenation could be possible within decades.

Adding to the Toolbox: Thyroid Artery Embolization

Drs Kaniksha Desai and Juan Camacho discuss thyroid artery embolization.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Latest News

The case emphasizes Bannwarth syndrome as a rare but treatable cause of neurologic deterioration in an older woman receiving surgical cancer care.

A meta-analysis suggests that large language model-simplified radiology reports improve patient understanding and readability while preserving high accuracy and completeness.

Neurologists Indu Subramanian and Alfonso Fasano discuss normal pressure hydrocephalus and why some of the classic dogma about this condition is wrong.

Ethicist Art Caplan discusses marketing promotions for expensive whole-body imaging.

Aging may not be permanent. Nir Barzilai explains how human cells reset to zero and why partial rejuvenation could be possible within decades.

Drs Kaniksha Desai and Juan Camacho discuss thyroid artery embolization.

News All Time

Surgery may not be required for some breast lesions, research suggests

Researchers at King's have found that certain breast lesions identified during routine screening may not always require removal. The findings could help reduce unnecessary procedures while maintaining high standards of patient ...

How hair and skin characteristics affect brain imaging: Making fNIRS research more inclusive

Functional near-infrared spectroscopy (fNIRS) is a promising non-invasive neuroimaging technique that works by detecting changes in blood oxygenation linked to neural activity using near-infrared light. Compared to fMRI and ...

Odds of repeat imaging higher for nonphysician practitioner interpretation

Imaging studies are more likely to be repeated within 90 days when the initial study is interpreted by a nonphysician practitioner (NPP) than when interpreted by a radiologist, according to a study published online Sept. ...

Radiologists probe aftermath of mass casualty terror attack

Researchers in Israel have detailed the experience of one hospital's radiology department during the mass casualty incident following the October 7, 2023, attack in southern Israel, to provide recommendations for future crisis ...

Randomized study comparing proton and photon radiation for breast cancer finds both preserve quality of life

The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report equally strong health-related quality of life with either treatment. Patients who received proton ...

Adaptive radiation therapy increases safety and preserves quality of life, says study

For patients with recurrent retroperitoneal sarcomas that cannot be treated surgically, treatment choices are limited. These tumors can grow quite large in the abdomen adjacent to vital organs or enmeshed within the bowel. ...

How doctors are using AI to improve radiation treatment

She has helped robots learn to get around indoors and pick up balls from the ground. And she has developed computer programs to monitor traffic at intersections.

Optic nerve added to multiple sclerosis criteria in major diagnostic update

The International Advisory Committee on Clinical Trials led a multinational panel updating the McDonald criteria, adding the optic nerve as a fifth anatomical location and allowing specific magnetic resonance imaging (MRI) ...

Guidelines developed for postmastectomy radiation therapy

In a clinical practice guideline published online Sept. 16 in Practical Radiation Oncology, recommendations are presented for the use of postmastectomy radiation therapy (PMRT).

Adding molecular breast imaging to digital breast tomosynthesis beneficial for dense breasts

For women with dense breasts, the addition of molecular breast imaging (MBI) as a supplement to digital breast tomosynthesis (DBT) increases overall and invasive cancer detection, according to a study published online Sept. ...

Mammograms may benefit women well into their 80s, study finds

For many older women, the question of whether to continue breast cancer screening has been uncertain. While most guidelines recommend mammograms up to age 74, advice for women 75 and older has been less clear. Now, a new ...

Turning off idling CT scanner saves 140kWh per week, enough to power an Australian home year round

CT scanners are usually left running 24/7 to be ready for patients who need emergency scans. Now researchers have conducted the first Australian study on the benefits of switching off radiology equipment when not in use.

CT scanners secretly waste more energy than used by a typical household, but there's a fix

Medical imaging is one of the biggest contributors of a hospital's energy use. Magnetic resonance imaging (MRI) and computed tomography (CT) are particularly carbon intensive, partly due to their need to be constantly cooled. ...

2016 to 2023 saw decline in U.S. pediatric radiologists

The number of U.S. pediatric radiologists declined from 2016 to 2023, according to a study published online Sept. 9 in the Journal of the American College of Radiology.

Innovative imaging techniques show what happens inside bones during hip replacement surgery

Uncemented hip replacement surgery uses implants with roughened surfaces designed to allow the patient's bone to grow directly onto the implant, creating a strong, natural biological bond. Unlike cemented implants, which ...

AI effective at detecting advanced breast cancer, but misses some cases

A Korean research team has reported that artificial intelligence (AI) used in mammography missed 14% of invasive breast cancers, the type where delayed diagnosis can directly impact patient survival.

Recommended News For You

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

New tumor therapy approach reduces costs and side effects while increasing accessibility

Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.

Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

Recommended Articles For You

Understanding Macrocytosis: Causes, Symptoms, and Treatment Options  

Unmasking the Subtle Symptoms of Colon Cancer 

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy 

Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Including Isatuximab with a Standard Backbone Enhances Multiple Myeloma Results.

2.

Charting the Course: From Young Adult Leukemia Patient to Oncologist.

3.

Screening for prostate cancer: is it time to give up digital rectal examination?

4.

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

5.

Charles III, King of Kings, is Cancerous.

1.

The Growing Crisis of Aplastic Anemia: A Call for Action

2.

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis

3.

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care

4.

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer

5.

Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

2.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

3.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot